Pharma Shares COVID-19 Voluntary Licensing Lessons Amid Debate Over Best Path to Access Pandemic Products 15/06/2023 Megha Kaveri One of the most intense debates in the pandemic accord negotiations is over how to fast-track the development and equitable rollout of vaccines and medicines, with pharmaceutical companies insisting that any infringement on intellectual property (IP) rights will stifle innovation and that voluntary arrangements are the way forward. A recent event to showcase voluntary licensing […] Continue reading -> How Global Action Can Meet Local Needs in Emerging Outbreaks 09/06/2023 Paul Adepoju More R&D into already known emerging disease threats, from Mpox to Lassa fever would go a long way to both bolster developing countries’ preparedness as well as protecting the world, experts argue. Member state negotiations resume next week over a draft WHO convention on pandemic prevention, preparedness and response – which is supposed to be […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
How Global Action Can Meet Local Needs in Emerging Outbreaks 09/06/2023 Paul Adepoju More R&D into already known emerging disease threats, from Mpox to Lassa fever would go a long way to both bolster developing countries’ preparedness as well as protecting the world, experts argue. Member state negotiations resume next week over a draft WHO convention on pandemic prevention, preparedness and response – which is supposed to be […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
WHO Ready For Marburg Vaccine Trials, Awaits Nod From Governments of Tanzania and Equatorial Guinea 29/03/2023 Megha Kaveri The World Health Organization (WHO) said that it is poised to begin clinical trials of three Marburg disease vaccine candidates if Tanzania and Equatorial Guinea, both struggling with outbreaks of the deadly disease, give the green light. About 2000 finished doses are available from vaccine developers and could be administered to the identified contacts of […] Continue reading -> Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts
New WHO Foundation Equity Fund Eyes AI-based Technology to Help Stroke Patients 07/03/2023 Maayan Hoffman A company that is using AI-powered technologies to help rehabilitate people with severe brain injuries, including those caused by strokes, has caught the eye of the World Health Organization (WHO) Foundation. The foundation’s Global Health Equity Fund (GHEF), formed in September will soon be ready to make its first round of investments. The WHO Foundation […] Continue reading -> Posts navigation Older postsNewer posts